Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Stramer

Showing results (51-60 of 258) with videos related to

Pageof 26
Sort By:
Transfusion|April 18, 2014
Probable transfusion-transmission of Anaplasma phagocytophilum by leukoreduced plateletsRebecca L Townsend, Erin D Moritz, Lawrence B Fialkow, et al.
Transfusion|January 28, 2009
Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United StatesShimian Zou, Edward P Notari, Chyang T Fang, et al.
Transfusion|December 10, 2021
Background rate of low-level HCV RNA in anti-HCV confirmed-positive and minipool nucleic acid test-nonreactive blood donationsJamel A Groves, Roger Y Dodd, Xiaomei Zhu, et al.
Transfusion|May 12, 2006
Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithmsSteven H Kleinman, Susan L Stramer, Jaye P Brodsky, et al.
Journal of Public Health Policy|December 18, 2024
Bridging the critical gap between infectious disease blood donation screening and connection to healthcare services: the American Chagas disease exampleM K Lynn, Mary Parker, Susan L Stramer, et al.
The American Journal of Tropical Medicine and Hygiene|July 25, 2012
Phylogenetic analysis of dengue virus types 1 and 4 circulating in Puerto Rico and Key West, Florida, during 2010 epidemicsGermán Añez, Daniel A R Heisey, Luz M Espina, et al.
Emerging Infectious Diseases|May 10, 2023
Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United StatesJames M Haynes, Roger Y Dodd, Lauren A Crowder, et al.
Transfusion|September 26, 2012
A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010Kerri A Dorsey, Erin D Moritz, Whitney R Steele, et al.
Transfusion|August 26, 2018
Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?Roger Y Dodd, Megan L Nguyen, David E Krysztof, et al.
Transfusion|February 16, 2023
Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?Lauren A Crowder, James M Haynes, Edward P Notari, et al.
Pageof 26

Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
Transfusion|April 18, 2014
Probable transfusion-transmission of Anaplasma phagocytophilum by leukoreduced plateletsRebecca L Townsend, Erin D Moritz, Lawrence B Fialkow, et al.
Transfusion|January 28, 2009
Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United StatesShimian Zou, Edward P Notari, Chyang T Fang, et al.
Transfusion|December 10, 2021
Background rate of low-level HCV RNA in anti-HCV confirmed-positive and minipool nucleic acid test-nonreactive blood donationsJamel A Groves, Roger Y Dodd, Xiaomei Zhu, et al.
Transfusion|May 12, 2006
Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithmsSteven H Kleinman, Susan L Stramer, Jaye P Brodsky, et al.
Journal of Public Health Policy|December 18, 2024
Bridging the critical gap between infectious disease blood donation screening and connection to healthcare services: the American Chagas disease exampleM K Lynn, Mary Parker, Susan L Stramer, et al.
The American Journal of Tropical Medicine and Hygiene|July 25, 2012
Phylogenetic analysis of dengue virus types 1 and 4 circulating in Puerto Rico and Key West, Florida, during 2010 epidemicsGermán Añez, Daniel A R Heisey, Luz M Espina, et al.
Emerging Infectious Diseases|May 10, 2023
Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United StatesJames M Haynes, Roger Y Dodd, Lauren A Crowder, et al.
Transfusion|September 26, 2012
A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010Kerri A Dorsey, Erin D Moritz, Whitney R Steele, et al.
Transfusion|August 26, 2018
Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?Roger Y Dodd, Megan L Nguyen, David E Krysztof, et al.
Transfusion|February 16, 2023
Low risk of human T-lymphotropic virus infection in U.S. blood donors; Is it time to consider a one-time selective testing approach?Lauren A Crowder, James M Haynes, Edward P Notari, et al.
Pageof 26